In all clinicopathologic forms hGH-V was present in the serum samples
derived frompatients with GTD (2 out of 3 cases of completemole,
7 out of 8 cases of partial hydatidiformmole, 1 out of 2 cases of invasive
mole and 2 out of 3 cases of choriocarcinoma).